Evidence map›Paper›PMID 41736082›Full record

ArticleBMC biology2026

NetG2P: Network-based genotype-to-phenotype transformation identifies key signaling crosstalk for prognosis in pan-cancer study.

Jonghyun Lee, Seok-Won Jang, Byungjo Lee, Jisu Shin, Jeong-Ryeol Gong, Dongkwan Shin

Abstract read
In one paragraph

Article in BMC biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jonghyun Lee *Research Institute, National Cancer Center, Goyang, 10408, Republic of Korea.
Seok-Won Jang *Research Institute, National Cancer Center, Goyang, 10408, Republic of Korea.
Byungjo LeeResearch Institute, National Cancer Center, Goyang, 10408, Republic of Korea.
Jisu ShinResearch Institute, National Cancer Center, Goyang, 10408, Republic of Korea.
Jeong-Ryeol GongDepartment of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.
Dongkwan ShinResearch Institute, National Cancer Center, Goyang, 10408, Republic of Korea. dshin@ncc.re.kr.

Funding

Korea Environmental Industry and Technology Institute RS-2025-02223058National Cancer Center NCC-2410750National Research Foundation of Korea NRF-2022R1A2C1010532
6 · The paper itself

Abstract

backgroundDespite advances in whole-genome sequencing and identifying cancer-associated genetic alterations, understanding the influence of multiple genetic alterations collectively on cancer phenotypes remains challenging, owing to mutation pattern complexity and variability. Here, we present the NETwork-based Genotype-to-Phenotype Transformation (NetG2P), which utilizes network propagation to translate genomic information into pathway interaction networks. Using the Cancer Genome Atlas dataset across 10 cancer types, we conducted a pan-cancer analysis using NetG2P to uncover critical oncogenic features associated with cancer prognosis using machine learning and explainable artificial intelligence models.

resultsOur results suggest that these features, which primarily represent signaling crosstalk, can serve as functional units for determining cancer prognosis. Network analysis of these critical oncogenic features reveals distinct patterns among cancer types, categorizing them into "distributed" and "modular" networks based on pathway interactions. Applying this technique to cancer cell line data has helped predict novel drug targets for high-risk groups and proposed candidates for drug repurposing.

conclusionsNetG2P generates patient-specific networks of critical oncogenic features and suggests personalized treatments, hence advancing precision medicine in oncology.

Indexed as

Gene Regulatory NetworksGenotypeNeoplasmsSignal TransductionHumansMachine LearningPhenotypePrognosisCritical oncogenic featureDrug repurposingGenotype-to-phenotype transformationMachine learningNetwork propagationPan-cancer analysisSignaling crosstalk

Identifiers

PMID41736082
PMCPMC13037077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.